We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Batavia

News List

Batavia Manufactures IAVI’s Lassa Fever Vax Candidate contractpharma
July 15, 2021
Batavia Biosciences has successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa fever vaccine candidate, rVSV∆G-LASV-GPC.
Batavia to Develop Clinical Process for RocketVax’s COVID-19 Vaccine contractpharma
July 09, 2021
After successful completion, Batavia will continue to scale-up and optimize the process for commercial scale.
Wistar and Batavia Collaborate to Manufacture Rubella Vaccine contractpharma
May 04, 2020
The Wistar Institute and Batavia Biosciences have launched a strategic collaboration aimed to streamline the clinical grade manufacture and global distribution of Wistar’s rubella vaccine seed stock commonly known as RA 27/3.